Search Results - "Bergstrom, Colin P"
-
1
Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest
Published in BMC cancer (16-04-2024)“…Therapies for metastatic castration-resistant prostate cancer (mCRPC) include targeting the androgen receptor (AR) with androgen receptor inhibitors (ARIs) and…”
Get full text
Journal Article -
2
The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement
Published in Leukemia research (01-01-2021)“…•LILRB4 is an immunoreceptor expressed on hematopoietic–lineage cells.•LILRB4 in animal models was demonstrated to orchestrate infiltration into the…”
Get full text
Journal Article -
3
Diagnostic Imaging for Breast Pain: A Teachable Moment
Published in JAMA internal medicine (01-10-2020)Get more information
Journal Article -
4
ASO Author Reflections: Clinical Correlates of Moderate-Penetrance Genes in Breast Cancer
Published in Annals of surgical oncology (01-06-2021)Get full text
Journal Article -
5
Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants
Published in Transfusion and apheresis science (01-10-2020)“…Venous and arterial thrombosis is one of the hallmarks of Antiphospholipid Antibody Syndrome (APS). The traditional treatment for individuals with APS and…”
Get full text
Journal Article -
6
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-07-2024)“…Purpose Lutetium-177 [ 177 Lu]Lu-PSMA-617 radioligand therapy (RLT) represents a significant advancement for metastatic castration-resistant prostate cancer…”
Get full text
Journal Article -
7
-
8
Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism
Published in Nature metabolism (01-06-2024)“…Nutrient handling is an essential function of the gastrointestinal tract. Hormonal responses of small intestinal enteroendocrine cells (EECs) have been…”
Get full text
Journal Article -
9
Mechanisms of glucagon degradation at alkaline pH
Published in Peptides (New York, N.Y. : 1980) (01-07-2013)“…•Because of its ability to prevent and treat hypoglycemia, glucagon shows great promise in closed loop treatment of diabetes.•However, glucagon degrades in…”
Get full text
Journal Article -
10
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates
Published in Anti-cancer drugs (01-01-2017)“…The aims of this study were to report the clinical outcomes in a cohort of men with high-risk prostate cancer treated with neoadjuvant docetaxel and…”
Get full text
Journal Article -
11
Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping
Published in Reproductive sciences (Thousand Oaks, Calif.) (01-11-2016)“…Although endometrial adenocarcinoma is usually treated with surgery, patients with metastatic disease have a poor prognosis. To address the need for better…”
Get more information
Journal Article -
12
The association of lymphotoxin-beta receptor with the subsequent diagnosis of incident gastrointestinal cancer: results from the Dallas Heart Study
Published in Journal of gastrointestinal oncology (01-02-2020)“…Lymphotoxin-beta receptor (LTβR) is an immunological protein associated with inflammation, and from preclinical studies is implicated in tumorigenesis. The…”
Get full text
Journal Article -
13
Biochemical stabilization of glucagon at alkaline pH
Published in Diabetes technology & therapeutics (01-11-2014)“…For patients with type 1 diabetes mellitus, a bihormonal artificial endocrine pancreas system utilizing glucagon and insulin has been found to stabilize…”
Get more information
Journal Article -
14
Clinicopathological features and clinical outcomes in individuals with Krukenberg tumors of colorectal origin
Published in Journal of clinical oncology (20-01-2024)“…191 Background: Krukenberg tumors (KT) are metastases to the ovary generally originating from a gastrointestinal primary such as colorectal carcinoma. The…”
Get full text
Journal Article -
15
Real world outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177-PSMA-vipivotide tetraxetan (Lu177-PVT)
Published in Journal of clinical oncology (01-02-2024)“…86 Background: Lu177-PVT is a novel radioligand, which was recently approved by the FDA to treat mCRPC. Real world data on its use and efficacy is limited. We…”
Get full text
Journal Article -
16
Assessing the clinical utility of rapid post-therapy whole-body digital SPECT/CT in evaluating early treatment response of 177 Lu-PSMA-617 treatment
Published in Journal of clinical oncology (01-02-2024)“…32 Background: Multi-detector cadmium-zinc-telluride (CZT) based whole-body digital SPECT/CT is a new generation of imaging system. We aim to assess the…”
Get full text
Journal Article -
17
Total and anatomically contextualized quantitative 18 F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression-free survival in patients with prostate cancer
Published in Journal of clinical oncology (01-02-2024)“…33 Background: PSMA PET has been shown to detect more metastasis and alter management at biochemical recurrence (BCR), but it remains to be determined that it…”
Get full text
Journal Article -
18
Actionable molecular alterations in veterans with advanced cholangiocarcinoma
Published in Journal of clinical oncology (20-01-2024)“…548 Background: Cholangiocarcinoma (CCA) requires integrated efforts to understand the heterogeneity in available molecular targets. Chemotherapy remains a…”
Get full text
Journal Article -
19
Survival impact of homologous recombination deficiency in veterans with cholangiocarcinoma including mutual exclusivity with pathogenic KRAS and TP53
Published in Journal of clinical oncology (20-01-2024)“…546 Background: Cholangiocarcinoma (CCA) has poor prognosis and limited treatment options. The US Veteran Health Administration’s (VHA) National Precision…”
Get full text
Journal Article -
20
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to 177LuLu-PSMA-617 in metastatic castration-resistant prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-07-2024)“…Lutetium-177 [177Lu]Lu-PSMA-617 radioligand therapy (RLT) represents a significant advancement for metastatic castration-resistant prostate cancer (mCRPC),…”
Get full text
Journal Article